Screening for genital human papillomavirus: Results from an international validation study on human papillomavirus sampling techniques

Diagnostic Molecular Pathology

Volumn 8, Issue 1, 1999, Pages 26-31

  De Sanjosé, Silvia ^a,g   Bosch, Xavier F ^a   Muñoz, Nubia ^b   Chichareon, Saibua ^c   Ngelangel, Cora ^d   Balagueró, Lorenzo ^e   Jacobs, Marcel V ^f   Meijer, Chris J L M ^f   Walboomers, Jan M M ^f  

^a HOSPITAL CLÍNIC   (Spain)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^d Clinical Epidemiology Unit   (Philippines)

^e UNIVERSITY OF BARCELONA   (Spain)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^g CATALAN INSTITUTE OF ONCOLOGY   (Spain)

Author keywords

Cervical cancer; Cervical screening; Human papillomavirus DNA detection; Polymerase chain reaction

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CANCER SCREENING; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PHILIPPINES; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTHERN BLOTTING; SPAIN; THAILAND; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; VALIDATION PROCESS; VIRUS DETECTION; WART VIRUS;

BIOPSY; DNA, VIRAL; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PHILIPPINES; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SPAIN; THAILAND; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0033058785     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019606-199903000-00005     Document Type: Article

References (17)

1. Bosch FX, Manos M, Muñoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995;87:796-802.
2. Chichareon S, Herrero R, Muñoz N, et al. Risk factors for cervical cancer in Thailand: a case-control study. J Natl Cancer Inst 1998; 90:50-7.
3. De Villiers EM, Schneider A, Miklaw H, et al. Human papillomavirus infections in women with and without abnormal cervical cytology. Lancet 1987;2:702-6.
4. IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 64. Human papillomaviruses. International Agency for Research on Cancer. Lyon, France, 1995.
5. Parkin DM, Whelan SL, Feraly J, Raymond L, Young J, eds. Cancer incidence in five continents. Vol. 7. IARC scientific publication no. 143. International Agency for Research on Cancer, Lyon, France 1997.
6. Ho GYF, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. New Engl J Med 1998;338:423-8.
7. Jacobs MV, Snijders PJF, Van den Brule AJC, Helmerhorst ThJM, Meijer CJLM, Walboomers JMM. A general primer GP5+/6+ mediated PCR-enzyme immunoassay method for rapid detection of 14 high risk and 6 low risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol 1997;35:791-5.
8. Melkert PWJ, Hopman E, Van den Brule AJC, et al. Prevalence of HPV in cytomorphologically normal cervical smears as determined by the polymerase chain reaction, is age-dependent. Int J Cancer 1993;53:919-23.
9. Ngelangel C, Muñoz N, Bosch FX, et al. Causes of cervical cancer in the Philippines: a case-control study. J Natl Cancer Inst 1998; 90:43-9.
10. Qu WM, Jiang G, Cruz Y, Chang CH, Ho GYF, Klein RS, Burk RD. PCR detection of human papillomavirus: comparison between MY09/11 and GP5+/6+ primer systems. J Clin Microbiol 1997; 35:1304-10.
11. Roda Husman AM de, Walboomers JMM, Meijer CJLM, et al. Analysis of cytomorphologically abnormal cervical scrapes for the presence of 27 mucosotropic human papillomavirus genotypes using polymerase chain reaction. Int J Cancer 1994;56:802-6.
12. Roda Husman AM de, Walboomers JMM, Van den Brule AJC, Meijer CJLM, Snijders PJF. The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by polymerase chain reaction. J Gen Virol 1995;76:1057-62.
13. Schneider A, Koutsky LA. Natural history and epidemiological features of genital HPV infection. In: Muñoz N, Bosch FX, Shah KV, Meheus A, eds. The epidemiology of human papillomavirus and cervical cancer. no. 119. Lyon, France: International Agency for Research on Cancer Scientific Publications, 1992:25-52.
14. Sun XW, Louise K, Ellerbrock TV, Chiasson MA, Brush TJ, Wright TC. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med 1997;337: 1343-9.
15. Walboomers JMM, Jacobs MV, Van Oostveen JW, Van den Brule AJC, Snijders PJF, Meijer CJLM. Detection of genital human papillomavirus infections and possible clinical implications. In: Gross G, von Krogh G, eds. Human papillomavirus infections in dermatovenerology. Chapter 19. London: CRC Press, 1997:341-64.
16. Walboomers JMM, Mullink H, Melchers WG, et al. Sensitivity of in situ detection with biotinylated probes of human papillomavirus type 16 DNA in frozen tissue sections of squamous cell carcinomas of the cervix. Am J Pathol 1988;131:587-94.
17. Walboomers JMM, Jacobs M, Manos M, et al. Human papillomavirus, a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;(in press).